Autologous haematopoietic stem cell transplantation versus low‐dose immunosuppression in secondary–progressive multiple sclerosis

BACKGROUND AND PURPOSE: Effectiveness of autologous haematopoietic stem cell transplantation (AHSCT) in relapsing–remitting multiple sclerosis (MS) is well known, but in secondary–progressive (SP)‐MS it is still controversial. Therefore, AHSCT activity was evaluated in SP‐MS using low‐dose immunosup...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariottini, Alice, Bulgarini, Giovanni, Forci, Benedetta, Innocenti, Chiara, Mealli, Fabrizia, Mattei, Alessandra, Ceccarelli, Chiara, Repice, Anna Maria, Barilaro, Alessandro, Mechi, Claudia, Saccardi, Riccardo, Massacesi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306891/
https://www.ncbi.nlm.nih.gov/pubmed/35146841
http://dx.doi.org/10.1111/ene.15280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306891/
https://www.ncbi.nlm.nih.gov/pubmed/35146841
http://dx.doi.org/10.1111/ene.15280

Ejemplares similares